お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
989548

アレルギー薬市場調査レポート:タイプ別(薬物アレルギー、食物アレルギー、吸入アレルギー)、治療別(抗アレルギー薬、免疫療法)、流通チャネル別-2025年までの予測-COVID-19の累積的影響

Allergy Drugs Market Research Report by Type (Drug Allergy, Food Allergy, and Inhaled Allergy), by Treatment (Anti-allergy Drugs and Immunotherapy), by Distribution Channels - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 183 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.25円
アレルギー薬市場調査レポート:タイプ別(薬物アレルギー、食物アレルギー、吸入アレルギー)、治療別(抗アレルギー薬、免疫療法)、流通チャネル別-2025年までの予測-COVID-19の累積的影響
出版日: 2021年02月11日
発行: 360iResearch LLP
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアレルギー薬の市場規模は、2020年に234億8,631万米ドル/ 205億9,324万ユーロとなりました。同市場は、2025年末までに336億4,294万米ドル/294億9,876万ユーロに達すると予測されています。

COVID-19は、未曾有の世界的な公衆衛生上の緊急事態であり、あらゆる業界に影響を及ぼしてきました。この長期的影響は、予測期間中に業界の成長に影響を与えると予測されています。私たちが進めている調査では、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げています。当レポートは、消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19について洞察を提供しています。

当レポートでは、アレルギー薬市場について調査し、市場の概要とともに、タイプ別、治療別、流通チャネル別、地域別の動向、COVID-19の累積的影響、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションと範囲
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画作成
    • 実行:調査実施
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • タイプ別見通し
  • 製品タイプ別見通し
  • 最終用途産業別見通し
  • 地域別見通し
  • 競合他社別見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響
  • 地理的な成長機会

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 世界のアレルギー薬市場、タイプ別

  • イントロダクション
  • 薬物アレルギー
  • 食物アレルギー
  • 吸入アレルギー

第7章 世界のアレルギー薬市場、治療別

  • イントロダクション
  • 抗アレルギー薬
    • 抗ヒスタミン薬
    • コルチコステロイド
    • ロイコトリエン阻害剤
  • 免疫療法
    • 皮下免疫療法(SCIT)舌下免疫療法(SLIT)

第8章 世界のアレルギー薬市場、流通チャネル別

  • イントロダクション
  • 病院薬局
  • オンライン薬局
  • 小売薬局とドラッグストア

第9章 南北アメリカのアレルギー薬市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋アレルギー薬市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカのアレルギー薬市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第13章 企業のユーザビリティプロファイル

  • AbbVie Inc.
  • Aimmune Therapeutics, Inc
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Amneal Pharmaceuticals PLC
  • Astra Biotech GmbH
  • AstraZeneca PLC
  • Aurobindo Pharma
  • Bayer AG
  • Cadila Healthcare Limited
  • Chongqing Huapont Pharmaceutical Co., Ltd
  • Cipla Inc
  • Dr. Reddy's Laboratories Ltd
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • HAL Allergy B.V.
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc
  • LETI Pharma GmBH
  • Lupin Limited
  • Magna Pharmaceuticals, Inc.
  • Merck & Co., Inc
  • Mylan N.V
  • Novartis AG
  • Sanofi SA
  • Stallergenes Greer Ltd
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

List of Figures

  • FIGURE 1. GLOBAL ALLERGY DRUGS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL ALLERGY DRUGS MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 12. GLOBAL ALLERGY DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 13. GLOBAL ALLERGY DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
  • FIGURE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2025
  • FIGURE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
  • FIGURE 21. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2025
  • FIGURE 23. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, 2020 VS 2025 (USD MILLION)
  • FIGURE 25. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), 2020 VS 2025 (USD MILLION)
  • FIGURE 29. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 VS 2025 (%)
  • FIGURE 30. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 VS 2025 (USD MILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2025
  • FIGURE 32. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2020 VS 2025 (USD MILLION)
  • FIGURE 33. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2020 VS 2025 (USD MILLION)
  • FIGURE 34. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2020 VS 2025 (USD MILLION)
  • FIGURE 35. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 36. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 38. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 39. BRAZIL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 40. CANADA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 41. MEXICO ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 42. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 43. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 44. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 46. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. CHINA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 48. INDIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. INDONESIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. JAPAN ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. THAILAND ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 56. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 58. FRANCE ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. GERMANY ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. ITALY ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. QATAR ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 63. RUSSIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 64. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 65. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 66. SPAIN ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 67. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 68. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 69. GLOBAL ALLERGY DRUGS MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 70. GLOBAL ALLERGY DRUGS MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 71. GLOBAL ALLERGY DRUGS MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALLERGY DRUGS MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. BRAZIL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CANADA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CANADA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. CANADA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. MEXICO ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. MEXICO ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. MEXICO ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. CHINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. CHINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. CHINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. INDIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. INDIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. INDIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. INDONESIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. JAPAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. JAPAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. JAPAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. THAILAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. THAILAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. THAILAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. FRANCE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. FRANCE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. FRANCE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. GERMANY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. GERMANY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. GERMANY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. ITALY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. ITALY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. ITALY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. QATAR ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. QATAR ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. QATAR ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. RUSSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. SPAIN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. SPAIN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. SPAIN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. GLOBAL ALLERGY DRUGS MARKET: SCORES
  • TABLE 107. GLOBAL ALLERGY DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 108. GLOBAL ALLERGY DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 109. GLOBAL ALLERGY DRUGS MARKET: RANKING
  • TABLE 110. GLOBAL ALLERGY DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 111. GLOBAL ALLERGY DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 112. GLOBAL ALLERGY DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 113. GLOBAL ALLERGY DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 114. GLOBAL ALLERGY DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 115. GLOBAL ALLERGY DRUGS MARKET: LICENSE & PRICING
目次
Product Code: MRR-DA051E6

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

  • 1. The Global Allergy Drugs Market is expected to grow from USD 23,486.31 Million in 2020 to USD 33,642.94 Million by the end of 2025.
  • 2. The Global Allergy Drugs Market is expected to grow from EUR 20,593.24 Million in 2020 to EUR 29,498.76 Million by the end of 2025.
  • 3. The Global Allergy Drugs Market is expected to grow from GBP 18,307.43 Million in 2020 to GBP 26,224.46 Million by the end of 2025.
  • 4. The Global Allergy Drugs Market is expected to grow from JPY 2,506,584.42 Million in 2020 to JPY 3,590,554.21 Million by the end of 2025.
  • 5. The Global Allergy Drugs Market is expected to grow from AUD 34,105.24 Million in 2020 to AUD 48,854.02 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Allergy Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the Allergy Drugs Market studied across Drug Allergy, Food Allergy, and Inhaled Allergy.
  • Based on Treatment, the Allergy Drugs Market studied across Anti-allergy Drugs and Immunotherapy. The Anti-allergy Drugs further studied across Antihistamines, Corticosteroids, and Leukotriene Inhibitors. The Immunotherapy further studied across Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT).
  • Based on Distribution Channels, the Allergy Drugs Market studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores.
  • Based on Geography, the Allergy Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Drugs Market including AbbVie Inc., Aimmune Therapeutics, Inc, ALK-Abello A/S, Allergy Therapeutics, Amneal Pharmaceuticals PLC, Astra Biotech GmbH, AstraZeneca PLC, Aurobindo Pharma, Bayer AG, Cadila Healthcare Limited, Chongqing Huapont Pharmaceutical Co., Ltd, Cipla Inc, Dr. Reddy's Laboratories Ltd, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc, LETI Pharma GmBH, Lupin Limited, Magna Pharmaceuticals, Inc., Merck & Co., Inc, Mylan N.V, Novartis AG, Sanofi SA, Stallergenes Greer Ltd, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
  • 5.Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Allergy Drugs Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Drugs Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Drugs Market?
  • 4. What is the competitive strategic window for opportunities in the Global Allergy Drugs Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Allergy Drugs Market?
  • 6. What are the modes and strategic moves considered suitable for entering the Global Allergy Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Type Outlook
  • 3.4. Treatment Outlook
  • 3.5. Distribution Channels Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of allergy globally
      • 5.1.1.2. Increasing development of allergy-specific drugs
      • 5.1.1.3. Changing lifestyle with increasing tobacco consumption
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
      • 5.1.3.2. Rising consumer awareness on food allergies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative drugs for allergy
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Allergy Drugs Market, By Type

  • 6.1. Introduction
  • 6.2. Drug Allergy
  • 6.3. Food Allergy
  • 6.4. Inhaled Allergy

7. Global Allergy Drugs Market, By Treatment

  • 7.1. Introduction
  • 7.2. Anti-allergy Drugs
    • 7.2.1. Antihistamines
    • 7.2.2. Corticosteroids
    • 7.2.3. Leukotriene Inhibitors
  • 7.3. Immunotherapy
    • 7.3.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)

8. Global Allergy Drugs Market, By Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies & Drug Stores

9. Americas Allergy Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Allergy Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. South Korea
  • 10.10. Thailand

11. Europe, Middle East & Africa Allergy Drugs Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis
  • 12.4. Competitor SWOT Analysis
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AbbVie Inc.
  • 13.2. Aimmune Therapeutics, Inc
  • 13.3. ALK-Abello A/S
  • 13.4. Allergy Therapeutics
  • 13.5. Amneal Pharmaceuticals PLC
  • 13.6. Astra Biotech GmbH
  • 13.7. AstraZeneca PLC
  • 13.8. Aurobindo Pharma
  • 13.9. Bayer AG
  • 13.10. Cadila Healthcare Limited
  • 13.11. Chongqing Huapont Pharmaceutical Co., Ltd
  • 13.12. Cipla Inc
  • 13.13. Dr. Reddy's Laboratories Ltd
  • 13.14. F. Hoffmann-La Roche AG
  • 13.15. GlaxoSmithKline PLC
  • 13.16. HAL Allergy B.V.
  • 13.17. Hikma Pharmaceuticals PLC
  • 13.18. Johnson & Johnson Services, Inc
  • 13.19. LETI Pharma GmBH
  • 13.20. Lupin Limited
  • 13.21. Magna Pharmaceuticals, Inc.
  • 13.22. Merck & Co., Inc
  • 13.23. Mylan N.V
  • 13.24. Novartis AG
  • 13.25. Sanofi SA
  • 13.26. Stallergenes Greer Ltd
  • 13.27. Sun Pharmaceutical Industries Ltd
  • 13.28. Teva Pharmaceutical Industries Ltd

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.